The 355
Image Credit: Freckle Films

On Friday, the star-packed female spy action film “The 355” is flailing in its box office debut, grossing $1.7 million from 3,145 theaters for a projected opening in the $4 million range.

The movie’s poor showing comes as a surge in COVID-19 cases due to the highly infectious omicron variant of COVID-19 further spooks older female moviegoers, the target demo for The 355. This film is directed by Simon Kinberg, which stars Jessica Chastain, Diane Kruger, Penélope Cruz, Diane Kruger, Lupita Nyong’o, and Fan Bingbing

Poor reviews also are not helping. Audiences liked it more, giving the movie a B+ Score.

The 355, a passion project for Jessica Chastain, is from FilmNation, and Universal is the first Hollywood studio release of 2022.

According to PostTrak, Friday’s audience was led by females (52 percent), with 80 percent of ticket buyers over 35, including 38 percent over 45.

The 355 is tipped to come in third for the weekend behind holdovers Spider-Man: No Way Home and Sing 2.

No Way Home, staying atop the chart, earned roughly $8 million from 4,012 theaters for a projected weekend of $30 million. By Sunday, the Marvel and Sony pic’s domestic total should be close to $670 million, which is one of the best numbers of all time, thanks to male moviegoers ages 18-34.

Illuminations and Universals’ Sing 2 is holding at No. 2 with a projected weekend of $10.3 million from 3,713 locations. Sometime over the weekend, it will become the first family animated film of the pandemic era to cross $100 million domestically.

Previous articleBen Affleck Reveals Why He Had The ‘Worst Experience’ Filing ‘Justice League’
Next articlePete Davidson Joins Jack Harlow On Stage To Perform ‘SUVs’
Alice is the Chief Editor with relevant experience of three years, Alice has founded Galaxy Reporters. She has a keen interest in the field of science. She is the pillar behind the in-depth coverages of Science news. She has written several papers and high-level documentation.

LEAVE A REPLY

Please enter your comment!
Please enter your name here